Innophos Holdings, Inc. (NASDAQ: IPHS) announced that it has acquired NutraGenesis, a
Under the terms of the purchase agreement,
"The addition of NutraGenesis' innovative, science-backed branded ingredients to our Food, Health and Nutrition portfolio more closely aligns
NutraGenesis, A Science-Based, Proprietary, Branded Ingredients Solutions Provider
- Strong and established portfolio of branded ingredients supplying leading
U.S. and international developers of branded nutritional ingredients - Highly complementary to recent Novel Ingredients acquisition and
Innophos' branded ingredients portfolio - Proven track record of partnering with clients to transform ingredients into marketable brands backed by scientific data that supports product efficacy and performance claims
- Serving attractive high-growth end-markets, including stress reduction, weight management, joint health, brain health and metabolic wellness, that are driven by health and wellness consumer trends
Acquisition Delivers Strong Shareholder Value
- All-cash transaction consideration of
$28 million financed by existing credit facility - LTM sales of
~$12m, and accretive adjusted EBITDA margin of 22% - Strong double-digit historical growth trajectory and outlook
- Asset-lite business model
- Accretive to earnings per share within the first year of combined operations
- Minimal impact on leverage
- Continued strong cash conversion cycle supports current dividend and strategic growth ambition
"Bringing NutraGenesis into our branded ingredients portfolio provides an immediate opportunity to combine their branding and marketing expertise with our sourcing, manufacturing and technology capabilities, to offer more differentiated ingredients solutions to our customers," Mink commented.
"We are confident that the acquisition of NutraGenesis will strengthen our growth profile and create sustainable value for our customers and shareholders," Mink said. "We remain focused on building out our Food, Health and Nutrition platform, driving sustainable growth and advancing toward our Vision 2022 goals."
Lazard acted as financial advisor to
Alantra acted as financial advisor to